| 21 |
|
Persistence of malignant hematopoietic progenitors in chronic myelogenous leukemia patients in complete cytogenetic remission following imatinib mesylate treatment/
|
Bhatia, R
|
W.B. Saunders Co., etc.]
|
2003
|
|
|
|
| 22 |
|
Persistent gamma-globin expression in adult transgenic mice is mediated by HPFH-2, HPFH-3, and HPFH-6 breakpoint sequences/
|
Katsantoni, E. Z
|
W.B. Saunders Co., etc.]
|
2003
|
|
|
|
| 23 |
|
PERSPECTIVE - Chronic myeloid leukemia: current treatment options/
|
Goldman, J M
|
W.B. Saunders Co., etc.]
|
2001
|
|
|
|
| 24 |
|
PERSPECTIVE - Discrepancies between genotype and phenotype in hematology: An important frontier/
|
Beutler, E
|
W.B. Saunders Co., etc.]
|
2001
|
|
|
|
| 25 |
|
PERSPECTIVE - Probability in transcriptional regulation and its implications for leukocyte differentiation and inducible gene expression/
|
Hume, D A
|
W.B. Saunders Co., etc.]
|
2000
|
|
|
|
| 26 |
|
PERSPECTIVE - Report of an international working group to standardize response criteria for myelodysplastic syndromes/
|
Cheson, B D
|
W.B. Saunders Co., etc.]
|
2001
|
|
|
|
| 27 |
|
PERSPECTIVES - Genetic hypercoagulability: Prevention suggests testing family members/
|
Mannucci, P M
|
W.B. Saunders Co., etc.]
|
2001
|
|
|
|
| 28 |
|
PERSPECTIVES - Genetic hypercoagulability: Screening should be an informed choice/
|
Green, D
|
W.B. Saunders Co., etc.]
|
2001
|
|
|
|
| 29 |
|
Pertinent questions/
|
Gertz, M
|
W.B. Saunders Co., etc.]
|
2003
|
|
|
|
| 30 |
|
PHAGOCYTES - Activation and priming of neutrophil nicotinamide adenine dinucleotide phosphate oxidase and phospholipase A2 are dissociated by inhibitors of the kinases p42ERK2 and p38SAPK and by methyl arachidonyl fluorophosphonate, the dual inhibitor of cytosolic and calcium-independent phospholipase A2/
|
Mollapour, E
|
W.B. Saunders Co., etc.]
|
2001
|
|
|
|
| 31 |
|
PHAGOCYTES - Alveolar macrophage deficiency in osteopetrotic mice deficient in macrophage colony-stimulating factor is spontaneously corrected with age and associated with matrix metalloproteinase expression and emphysema/
|
Shibata, Y
|
W.B. Saunders Co., etc.]
|
2001
|
|
|
|
| 32 |
|
PHAGOCYTES - An adherent condition is required for formation of multinuclear osteoclasts in the presence of macrophage colony-stimulating factor and receptor activator of nuclear factor kB ligand/
|
Miyamoto, T
|
W.B. Saunders Co., etc.]
|
2001
|
|
|
|
| 33 |
|
PHAGOCYTES - A novel syndrome of variant leukocyte adhesion deficiency involving defects in adhesion mediated by b1 and b2 integrins/
|
Harris, E S
|
W.B. Saunders Co., etc.]
|
2001
|
|
|
|
| 34 |
|
PHAGOCYTES - A proteolytically truncated form of free CD18, the common chain of leukocyte integrins, as a novel marker of activated myeloid cells/
|
Drbal, K
|
W.B. Saunders Co., etc.]
|
2001
|
|
|
|
| 35 |
|
PHAGOCYTES - Autosomal recessive chronic granulomatous disease caused by defects in NCF-1, the gene encoding the phagocyte p47-phox: Mutations not arising in the NCF-1 pseudogenes/
|
Noack, D
|
W.B. Saunders Co., etc.]
|
2001
|
|
|
|
| 36 |
|
PHAGOCYTES - Bifurcation of osteoclasts and dendritic cells from common progenitors/
|
Miyamoto, T
|
W.B. Saunders Co., etc.]
|
2001
|
|
|
|
| 37 |
|
PHAGOCYTES - BRIEF REPORTS - A novel CBFA2 single-nucleotide mutation in familial platelet disorder with propensity to develop myeloid malignancies/
|
Buijs, A
|
W.B. Saunders Co., etc.]
|
2001
|
|
|
|
| 38 |
|
PHAGOCYTES - BRIEF REPORTS - Erythropoietin expression in primary rat Sertoli and peritubular myoid cells/
|
Magnanti, M
|
W.B. Saunders Co., etc.]
|
2001
|
|
|
|
| 39 |
|
PHAGOCYTES - BRIEF REPORTS - Inhibitor of histone deacetylation, depsipeptide (FR901228), in the treatment of peripheral and cutaneous T-cell lymphoma: A case report/
|
Piekarz, R L
|
W.B. Saunders Co., etc.]
|
2001
|
|
|
|
| 40 |
|
PHAGOCYTES - BRIEF REPORTS - In vitro all-trans retinoic acid sensitivity of acute promyelocytic leukemia blasts: A novel indicator of poor patient outcome/
|
Cassinat, B
|
W.B. Saunders Co., etc.]
|
2001
|
|
|
|
기사
(203)
